Document is current
Any future updates will be listed below
-
Authors
Kutz, Alexander
Koch, Daniel
Conca, Antoinette
Baechli, Ciril
Haubitz, Sebastian
Regez, Katharina
Schild, Ursula
Caldara, Zeljka
Ebrahimi, Fahim
Bassetti, Stefano
Eckstein, Jens
Beer, Juerg
Egloff, Michael
Kaplan, Vladimir
Ehmann, Tobias
Hoess, Claus
Schaad, Heinz
Wagner, Ulrich
de Geest, Sabina
Schuetz, Philipp
Mueller, Beat
-
Funding
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (407440_167376)
Research council of the Kantonsspital Aarau (1410.000.086)
Wissenschaft & Weiterbildung (W&W) Fonds of the Kantonsspital Aarau (140.000.495)
Hugo und Elsa Isler Fonds of the Argovian Department of Health and Social Affairs (Not applicable)
- License Information
-
More Information
Article History
Received: 4 November 2018
Accepted: 27 March 2019
First Online: 23 April 2019
Ethics approval and consent to participate
: All patients will be informed by a flyer about their study participation after admission. As a quality improvement and control study, the institutional review board (IRB) of Northwestern Switzerland has approved the study and waived the need for individual informed consent by formulating a declaration of no objection (AG/SO 2009/074 and EKNZ BASEC PB_2017–00449). A trial registration is therefore not applicable.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
